Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170718591> ?p ?o ?g. }
- W3170718591 endingPage "9" @default.
- W3170718591 startingPage "1" @default.
- W3170718591 abstract "Septic shock is the most serious complication of sepsis, leading to unacceptably high morbidity and mortality worldwide. Fluid resuscitation using crystalloids has become the mainstay of early and aggressive treatment of severe sepsis and septic shock, while increased daily fluid balances from day 2 until day 7 have been related with increased mortality. Recently, pharmacological management has been recommended to combine with appropriate fluid resuscitation for the treatment of septic shock. In this study, we compared the clinical efficacy of restricting volumes of resuscitation fluid strategy with or without intravenous infusion of ulinastatin (UTI) in treating patients with septic shock and additionally examined the patient’s changes of the extravascular lung water index (EVLWI), pulmonary vascular permeability index (PVPI), systemic vascular resistance index (SVRI), cardiac function, lactic acid (LA) level, coagulation function, and renal function. The study included 182 patients with septic shock, among which 89 patients had undergone restricting volumes of resuscitation fluid strategy with intravenous infusion of UTI and 93 patients had undergone restricting volumes of resuscitation fluid strategy alone. It was found that patients with septic shock after restricting volumes of resuscitation fluid strategy with intravenous infusion of UTI showed an increased SVRI concomitant with declined PVPI and EVLWI, increased mean artery pressure (MAP), cardiac output (CO), left ventricular ejection fraction (LVEF), stroke volume (SV), and heart rate (HR), declined levels of cardiac troponin I (cTnI), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and C-reactive protein (CRP), reduced LA level along with shortened prothrombin time (PT) and partially activated thrombin time (PATT), and decreased levels of blood urea nitrogen (BUN), creatinine (Cr), and uric acid (UA) when comparable to those after restricting volumes of resuscitation fluid strategy alone ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ). We also observed fewer scores of the Acute Physiology and Chronic Health Evaluation (APACHE II) and the sequential organ failure assessment (SOFA) in patients undergoing restricting volumes of resuscitation fluid strategy with intravenous infusion of UTI than those undergoing restricting volumes of resuscitation fluid strategy alone ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ). According to the above data, it is concluded that UTI as an adjuvant therapy for restricting volumes of resuscitation fluid strategy in treating septic shock may decrease the LA level, attenuate the inflammatory response, reduce vascular permeability, prevent pulmonary edema, and restore cardiac and renal functions." @default.
- W3170718591 created "2021-06-22" @default.
- W3170718591 creator A5026888643 @default.
- W3170718591 creator A5070538645 @default.
- W3170718591 creator A5073250574 @default.
- W3170718591 date "2021-06-16" @default.
- W3170718591 modified "2023-10-16" @default.
- W3170718591 title "Ulinastatin as an Adjuvant Therapy to Restricting Volumes of Resuscitation Fluid Strategy for Patients with Septic Shock after Initial Management" @default.
- W3170718591 cites W1967278969 @default.
- W3170718591 cites W1968112127 @default.
- W3170718591 cites W2007890540 @default.
- W3170718591 cites W2015416898 @default.
- W3170718591 cites W2025723164 @default.
- W3170718591 cites W2041512359 @default.
- W3170718591 cites W2042759253 @default.
- W3170718591 cites W2078323810 @default.
- W3170718591 cites W2081415485 @default.
- W3170718591 cites W2097786723 @default.
- W3170718591 cites W2132837977 @default.
- W3170718591 cites W2144589352 @default.
- W3170718591 cites W2156938534 @default.
- W3170718591 cites W2159591164 @default.
- W3170718591 cites W2160135708 @default.
- W3170718591 cites W2175194395 @default.
- W3170718591 cites W2177398380 @default.
- W3170718591 cites W2280404143 @default.
- W3170718591 cites W2339358538 @default.
- W3170718591 cites W2342606003 @default.
- W3170718591 cites W2516982490 @default.
- W3170718591 cites W2523170972 @default.
- W3170718591 cites W2553300030 @default.
- W3170718591 cites W2560578714 @default.
- W3170718591 cites W2564096200 @default.
- W3170718591 cites W2601862041 @default.
- W3170718591 cites W2741573943 @default.
- W3170718591 cites W2745212246 @default.
- W3170718591 cites W2755519540 @default.
- W3170718591 cites W2757089737 @default.
- W3170718591 cites W2765967969 @default.
- W3170718591 cites W2780715783 @default.
- W3170718591 cites W2782975824 @default.
- W3170718591 cites W2794624521 @default.
- W3170718591 cites W2801360758 @default.
- W3170718591 cites W2804699844 @default.
- W3170718591 cites W2808829764 @default.
- W3170718591 cites W2810162720 @default.
- W3170718591 cites W2872858259 @default.
- W3170718591 cites W2889382826 @default.
- W3170718591 cites W2914941679 @default.
- W3170718591 cites W2937942556 @default.
- W3170718591 cites W2982027455 @default.
- W3170718591 cites W2993313378 @default.
- W3170718591 cites W2998853022 @default.
- W3170718591 cites W3000726620 @default.
- W3170718591 cites W3016555942 @default.
- W3170718591 cites W3023757607 @default.
- W3170718591 cites W4200047370 @default.
- W3170718591 doi "https://doi.org/10.1155/2021/4231454" @default.
- W3170718591 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8221865" @default.
- W3170718591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34221069" @default.
- W3170718591 hasPublicationYear "2021" @default.
- W3170718591 type Work @default.
- W3170718591 sameAs 3170718591 @default.
- W3170718591 citedByCount "1" @default.
- W3170718591 countsByYear W31707185912021 @default.
- W3170718591 crossrefType "journal-article" @default.
- W3170718591 hasAuthorship W3170718591A5026888643 @default.
- W3170718591 hasAuthorship W3170718591A5070538645 @default.
- W3170718591 hasAuthorship W3170718591A5073250574 @default.
- W3170718591 hasBestOaLocation W31707185911 @default.
- W3170718591 hasConcept C126322002 @default.
- W3170718591 hasConcept C139940330 @default.
- W3170718591 hasConcept C164705383 @default.
- W3170718591 hasConcept C178853913 @default.
- W3170718591 hasConcept C2776452961 @default.
- W3170718591 hasConcept C2777628635 @default.
- W3170718591 hasConcept C2777953023 @default.
- W3170718591 hasConcept C2778165595 @default.
- W3170718591 hasConcept C2778198053 @default.
- W3170718591 hasConcept C2778384902 @default.
- W3170718591 hasConcept C2781300812 @default.
- W3170718591 hasConcept C31861589 @default.
- W3170718591 hasConcept C42219234 @default.
- W3170718591 hasConcept C71924100 @default.
- W3170718591 hasConcept C78085059 @default.
- W3170718591 hasConcept C84393581 @default.
- W3170718591 hasConceptScore W3170718591C126322002 @default.
- W3170718591 hasConceptScore W3170718591C139940330 @default.
- W3170718591 hasConceptScore W3170718591C164705383 @default.
- W3170718591 hasConceptScore W3170718591C178853913 @default.
- W3170718591 hasConceptScore W3170718591C2776452961 @default.
- W3170718591 hasConceptScore W3170718591C2777628635 @default.
- W3170718591 hasConceptScore W3170718591C2777953023 @default.
- W3170718591 hasConceptScore W3170718591C2778165595 @default.
- W3170718591 hasConceptScore W3170718591C2778198053 @default.
- W3170718591 hasConceptScore W3170718591C2778384902 @default.
- W3170718591 hasConceptScore W3170718591C2781300812 @default.
- W3170718591 hasConceptScore W3170718591C31861589 @default.